---
title: "Geron reports inducement stock option grants for 202,500 shares at $1.44 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293513728.md"
description: "Geron Corporation granted stock options for 202,500 shares to five new employees at an exercise price of $1.44 per share. The awards vest over four years and have a 10-year term."
datetime: "2026-07-22T20:01:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293513728.md)
  - [en](https://longbridge.com/en/news/293513728.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293513728.md)
---

# Geron reports inducement stock option grants for 202,500 shares at $1.44 each

-   Geron granted stock options covering 202,500 common shares to five newly hired employees, effective July 17, 2026. \* Options carry an exercise price of USD 1.44 per share, matching the stock’s closing price on the grant date. \* Awards have a 10-year term, vesting over four years with 12.5% at six months, then monthly installments over 42 months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607221601PRIMZONEFULLFEED9766539) on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [GERN.US](https://longbridge.com/en/quote/GERN.US.md)

## Related News & Research

- [Geron Q2 2026 earnings: RYTELO revenue grows as inventory costs weigh on margins](https://longbridge.com/en/news/294961334.md)
- [Geron Q2 FY26 net loss widens to $16.7 million; revenue rises 11% to $57.5 million vs Q1 FY26](https://longbridge.com/en/news/294955961.md)
- [Vor Bio grants stock options for 32,550 shares, RSUs for 6,900 shares to new hires under inducement plan](https://longbridge.com/en/news/294736248.md)
- [Candel Therapeutics grants inducement stock options for 30,800 shares at $10.01 each](https://longbridge.com/en/news/294731432.md)
- [X4 Pharmaceuticals issues inducement stock options for 12,000 shares at $3.98 each](https://longbridge.com/en/news/294736223.md)